Alternative complex III (ACIII) is a key component of the respiratory and/or photosynthetic electron transport chains of many bacteria 1-3 . Like complex III (also known as the bc 1 complex), ACIII catalyses the oxidation of membrane-bound quinol and the reduction of cytochrome c or an equivalent electron carrier. However, the two complexes have no structural similarity 4-7 . Although ACIII has eluded structural characterization, several of its subunits are known to be homologous to members of the complex iron-sulfur molybdoenzyme (CISM) superfamily 8 , including the proton pump polysulfide reductase 9,10 . We isolated the ACIII from Flavobacterium johnsoniae with native lipids using styrene maleic acid copolymer 11-14 , both as an independent enzyme and as a functional 1:1 supercomplex with an aa 3 -type cytochrome c oxidase (cyt aa 3 ). We determined the structure of ACIII to 3.4 Å resolution by cryo-electron microscopy and constructed an atomic model for its six subunits. The structure, which contains a [3Fe-4S] cluster, a [4Fe-4S] cluster and six haem c units, shows that ACIII uses known elements from other electron transport complexes arranged in a previously unknown manner. Modelling of the cyt aa 3 component of the supercomplex revealed that it is structurally modified to facilitate association with ACIII, illustrating the importance of the supercomplex in this electron transport chain. The structure also resolves two of the subunits of ACIII that are anchored to the lipid bilayer with N-terminal triacylated cysteine residues, an important post-translational modification found in numerous prokaryotic membrane proteins that has not previously been observed structurally in a lipid bilayer.
Letter reSeArCH subunits of polysulfide reductase from Thermus thermophilus (PsrABC) 16 , a member of the CISM superfamily (Supplementary Discussion). Like PsrC, ActC contains no cofactors, but it does contain the proposed site for the oxidation of menaquinol. Residues at the menaquinol-binding site identified in PsrC 16 are not conserved in ActC 17 . Although menaquinone is not observed in the cryo-EM map, we propose that the ActC residues His133 and Asp164 form the menaquinol-binding site in ActC near the interface with ActB (Extended Data Fig. 6 ). These two residues are conserved in ActC sequences and there is a crevice between transmembrane helices 3 (TM3) and 4 (TM4) of ActC that would provide access to the substrate in the membrane bilayer.
The N-terminal portion of ActB is homologous to the PsrA subunit of polysulfide reductase, which contains the molybdenum cofactor, but the molybdenum cofactor is absent in ActB 4 . The C-terminal domain of ActB is homologous to PsrB, and both ActB and PsrB contain ironsulfur clusters. Like PsrB, ActB from F. johnsoniae is expected to contain four iron-sulfur clusters, but only two are observed in the cryo-EM map (Extended Data Fig. 7 ). There is one [3Fe-4S] cluster near the interface with ActC, about 10 Å from the proposed site of menaquinol oxidation, and one [4Fe-4S] cluster about 9 Å further away. There are two additional cysteine clusters present in the structure of ActB, but the cryo-EM map does not show iron-sulfur clusters at these locations. Instead, we observe disulfide bonds (Cys965-Cys938 and Cys971-Cys769) within these two cysteine clusters in ActB. The substitution of proposed [4Fe-4S] clusters by disulfide bonds may be a genuine aspect of the structure or may result from oxidation that occurred during sample preparation. However, if these two 'missing' [4Fe-4S] clusters were present, they would form a dead-end for electron transfer from the [3Fe-4S] cluster of ActB, suggesting that their absence from the structure is not an artefact.
The [3Fe-4S] cluster in ActB is the most probable initial oxidant of menaquinol bound to ActC, and is 12.3 Å from the nearest haem c in ActA. The five haems c in ActA plus the single haem c in ActE form a probable electron transfer wire from the [3Fe-4S] cluster in ActB, with the largest edge-to-edge distance of 9.2 Å between adjacent haems (Fig. 2b) . The [4Fe-4S] cluster in ActB appears to be off-pathway and its function remains to be determined.
In all Flavobacteria, including F. johnsoniae, ActA is predicted to have a monohaem domain at the N terminus in addition to the pentahaem domain at the C terminus (Supplementary Discussion). Mass spectrometry analysis shows that the N-terminal monohaem domain is present in the preparation (Extended Data Fig. 1 ), but no density can be assigned to this entire domain. The inability to resolve the monohaem domain may result from flexibility of the domain. Full-atom molecular dynamics simulations were performed for the entire structure of ACIII embedded in a phospholipid bilayer to determine the stability and dynamics of the structure (Extended Data Fig. 8 ). Notably, the pentahaem domain of ActA had the largest root-mean-square deviation (r.m.s.d.), which arises mainly from the transmembrane α-helix connected to the missing monohaem domain; this is consistent with the monohaem domain being unobservable owing to a variable position in the complex. Although ActE also had a substantial r.m.s.d., it did not appear to correlate with disorder in the cryo-EM map.
ActD and ActF are transmembrane subunits without bound cofactors, and both interact with ActC. It has not been established whether ACIII generates a proton motive force coupled to electron transport 18 . The absence of redox centres in ActC, ActD and ActF suggests that if ACIII contributes to the transmembrane proton gradient, it does not use the bifurcation-type Q-cycle mechanism of canonical complex III 19 , but instead functions as a true proton pump with a mechanism that resembles that of complex I 20 . ActD has two transmembrane α-helices that cross within the membrane and are adjacent to ActC. Both N and C termini are within the cytoplasm and combine to form a single globular domain that rests on the cytoplasmic surface of ActC. The ten transmembrane α-helices of ActF form a pseudo two-fold axis of symmetry with the ten transmembrane α-helices of ActC (Extended Data Fig. 5 ), despite the fact that ActF has less than 20% sequence identity with ActC. If ACIII is a proton pump, it is likely that conserved polar residues within the bilayer will have important roles.
The structure of ACIII reveals eleven ordered phospholipid molecules as well as triacylated cysteine residues at the N termini of ActB ( Fig. 3a) and ActE (Extended Data Fig. 7 ). The anchoring of bacterial membrane proteins by an N-terminal triacylated cysteine is a wellcharacterized phenomenon 21 ; however, to our knowledge, this is the first time the structure of a triacylated cysteine residue has been determined in the context of a membrane protein. Both lipid anchors are tilted with respect to the plane of the lipid bilayer ( Fig. 2a ), restricting the ability of other lipids to pack around them. This feature could alter the mechanical properties of the adjacent portion of the membrane bilayer, and also guide conformational changes in the ACIII protein. Notably, the two N-terminal lipid anchors are adjacent to each other in the membrane. These lipid anchors probably help ACIII to assemble and keep the monohaem ActE bound to the complex. The eleven lipids that are resolved adjacent to the transmembrane α-helices accommodate the rugged protein surface of the complex (Fig. 3b , Extended Data Fig. 7 ). The head groups of the lipids could not be identified and were all modelled as phosphatidylethanolamine. There are two 'hot spots' for resolved lipids: the cytoplasmic interface between ActC and ActF; and the vicinity of the triacylated cysteine of ActB, which is near the proposed entry point for menaquinol into the complex. All eleven of the resolved lipids remained bound to the protein throughout 250 ns of molecular dynamics simulation (Extended Data Fig. 8 ), supporting the ability of SMA nanodiscs to preserve some native lipid-protein interactions and suggesting a functional role for the lipids. A large number of annular lipids, including those modelled in the structure, were observed to associate with the protein from the in silico bilayer.
Frequently, the subunits encoding ACIII are within an operon that includes subunits of an associated complex IV 3 (cyt aa 3 or cyt caa 3 ). We find that the sequences of subunit III from complex IVs that are associated with ACIII have unusual features that distinguish them from the canonical subunit III (Supplementary Discussion). Covalently bonded cysteines are shown along with the core iron-sulfur clusters (circled in orange). Both covalently linked cysteines and axial-coordinating residues are shown for haems (circled in pink). b, The edge-to-edge distances between cofactors.
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Whereas subunit III of complex IV generally contains seven transmembrane α-helices, those that are associated with ACIII lack TM1 and TM2 ( Fig. 4a ). Although only parts of subunit III of cyt aa 3 are resolved to better than 4 Å, the density for cyt aa 3 has sufficient resolution to identify five α-helices from the structure. A homology model of subunit III from F. johnsoniae cyt aa 3 was built on the basis of the structure of TM3 to TM7 of subunit III from Rhodobacter sphaeroides cyt aa 3 , and fit into the ACIII-cyt aa 3 supercomplex density map (Extended Data Fig. 9 ) with high fidelity. The deletion of the first two transmembrane α-helices in subunit III of cyt aa 3 appears to be a necessary adaptation to enable formation of the supercomplex with ACIII. It is notable that the same two helices in subunit III are also absent in the cyt aa 3 obligatory cyt bcc-cyt aa 3 supercomplex found in Actinobacteria (for example, Corynebacterium glutamicum and Mycobacterium tuberculosis) 22 .
The sequence analysis also reveals that the loop between TM5 and TM6 of subunit III in the cyt aa 3 that is part of the supercomplex is much longer in F. johnsoniae (and all Flavobacteria) than in other organisms. Typically, this loop contains eight residues, but in F. johnsoniae it contains 121 residues ( Fig. 4a ). Part of this long loop fits in a groove between ActB and ActD of ACIII on the periplasmic side of the membrane (Extended Data Fig. 9 ). The structural model reveals a π-cation interaction between Trp188 of subunit III and Arg868 of ActB ( Fig. 4b) , both of which are conserved among organisms containing subunit III with a long loop between TM5 and TM6 (Extended Data Fig. 9 ). This specific and strong interaction stabilizes the ACIII-cyt aa 3 supercomplex and appears to be a second adaptation that enables the formation of a supercomplex with ACIII. The contact between the periplasmic loop of subunit III of cyt aa 3 and ACIII is the only observed direct contact between the two complexes. The five well-resolved transmembrane α-helices of subunit III of cyt aa 3 are angled away from ACIII with only the tip of TM6 of subunit III touching ActF, forming a wedge-like space between the membrane domains of ACIII and cyt aa 3 . The decrease of resolution in the portions of cyt aa 3 that are distant from the interface with ACIII suggests that there may be several conformations of the supercomplex that are all tethered by the loop in cyt aa 3 . The loop could, therefore, serve as a hinge, enabling the membrane domains of ACIII and cyt aa 3 to swing into contact transiently.
Using the location of TM3 to TM7 of subunit III within the supercomplex as a guide enables a model of the entire cyt aa 3 to be placed within the density map for the supercomplex (Extended Data Fig. 9 ).
In the resulting model, there is a considerable distance (56 Å) between the haem c in ActE of ACIII and Cu A within subunit II of cyt aa 3 . Electron transfer within the supercomplex does not require the addition of exogenous cyt c, which is also the case for the cyt bcc-cyt aa 3 supercomplex from C. glutamicum 23 . It is possible, although it seems unlikely, that there is a subset of conformations in which ActE comes close enough to cyt aa 3 for direct electron transfer. It is noteworthy that the monohaem domain of ActA has substantial sequence homology (around 30% identity) with the haem c domain that is present at the C terminus of subunit II of cyt caa 3 from T. thermophilus. This observation suggests that the ActA monohaem domain, which we postulate to be highly mobile in the structure (see above), may be able to interact with subunit II of cyt aa 3 and shuttle electrons from the ActE monohaem domain to subunit II of cyt aa 3 . As such, electron transfer within the supercomplex may require the monohaem domain of ACIII to swing back and forth between ACIII and cyt aa 3 to shuttle electrons ( Fig. 4c ). Additional experimental work will be required to test this model and, indeed, to determine the physiological advantage of forming the supercomplex.
We would like to note that, contemporaneously with our studies, Sousa et al. 24 determined the structure of the homologous ACIII from Rhodothermus marinus by cryo-EM at 3.9 Å resolution. Aside from species-specific variations, the reported structures of the ACIIIs of F. johnsoniae and R. marinus are compatible. The observation made here that, like canonical complexes III and IV, ACIII and an adapted complex IV can also form a supercomplex hints at the importance of supercomplexes in oxidative phosphorylation. We demonstrate that high-resolution cryo-EM with SMA nanodiscs, which preserves native protein-protein and protein-lipid interactions, is ideally suited to have an important role in future studies.
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MEthodS
Bacterial strain and growth conditions. Flavobacterium johnsoniae ATCC 17061 strain UW101 was used in this study. The strain was a gift from M. McBride at the University of Wisconsin, Milwaukee. The cells were grown in casitone-yeast extract medium at 30 °C under high aerobic conditions (500 ml cultures in 2 l flasks) 25 . Membrane preparation and protein purification. Cells grown overnight were collected by centrifugation (14,000g for 10 min). The cell pellet from 12 l of culture (~2.5 g l −1 ) was resuspended in ~200 ml of 20 mM Tris-HCl buffer, pH 8 (buffer A) with 5 mM MgSO 4 , DNase I (Sigma) and a protease inhibitor cocktail (Sigma). This suspension was passed three times through a Microfluidizer at a pressure of 80,000 psi to disrupt the cells. The cell extract was centrifuged at 14,000g for 10 min to remove unbroken cells. Membranes were obtained after centrifugation at 185,500g for 4 h. Under the above growth conditions, the membranes contained ACIII, cyt aa 3 and cyt bd. The membrane pellet was solubilized by using either a traditional detergent or the SMA copolymer. Purification using Triton X-100 and DDM. The membrane pellet was resuspended in buffer A (~50 mg ml −1 ) along with 300 mM NaCl, and solubilized by the addition of Triton X-100 (Fisher Scientific) to a final concentration of 4%. The solution was incubated at 4 °C for 2 h with mild agitation. The suspension was cleared by centrifugation at 185,500g for 1 h, after which the detergent was diluted fourfold by adding three volumes of buffer A to the supernatant. The diluted supernatant was then added to a chromatography column containing 10 ml of Ni-NTA resin (Qiagen) pre-equilibrated with 20 mM Tris-HCl pH 8 containing 0.05% Triton X-100 and 0.15 M NaCl (buffer B). The resin was washed with about ten column volumes of buffer B to remove any unbound sample. Detergent exchange to n-dodecyl-β-d-maltoside (DDM; Anatrace) was carried out by washing with buffer B containing 0.05% DDM instead of Triton X-100 (buffer C). The column was further washed with five column volumes of buffer C containing 10 mM imidazole to remove the loosely bound proteins from the resin. The proteins that were well bound to the resin were eluted using 100 mM imidazole in buffer C. The eluent was concentrated to around 3 ml using Amicon Ultra-15 filters (Millipore) with a 100-kDa cutoff. The excess imidazole was removed by dialysis against buffer C. The yield of protein obtained was about 0.3 mg l −1 of ACIII and 0.16 mg l −1 of cyt aa 3 from 12 l of culture. When indicated, the proteins were further purified by gel filtration chromatography using a Superdex 200 10/300 GL column (GE Healthcare Life Sciences). The purified proteins were stored at −80 °C after adding glycerol to a final concentration of 10%. Purification using SMA copolymer. The SMA copolymer SMA 3000HNA (styrene maleic acid copolymer, ~3:1 molar ratio of styrene:maleic acid) was a gift from T. Bricker (Louisiana State University) who used SMA copolymer made by Cray Valley USA (now Total Petrochemicals & Refining USA) successfully for the studies of photosystem from spinach thylakoids 26 . Additional SMA 3000HNA was provided by Total Petrochemicals & Refining USA as an aqueous solution of 25.6% (w/v) SMA. We also used a similar product, Xiran SL25010 S25, provided by Polyscope Polymers B. V., with similar results. These polymer preparations are provided as aqueous solutions of the sodium salt, and the polymer solutions were simply diluted to the final desired percentage to use directly for the solubilization of membranes. The purification protocol with the SMA copolymer was similar to that described with detergents with the following differences. After the membrane pellet was resuspended, the SMA solution was added dropwise to a final concentration of 1% with continuous stirring. After incubation for 1 h at room temperature, the solution was centrifuged at 185,500g for 1 h to remove unsolubilized particles. The supernatant was loaded directly to the Ni-NTA column equilibrated with 20 mM Tris-HCl pH 8, 0.15 M NaCl. The remaining steps of the purification were as described above. After solubilization of the membrane suspension with 1% SMA 3000HNA, no additional SMA or detergents were added and were not needed to maintain the solubilized proteins in solution. The yield of protein after the use of the SMA copolymer for solubilization was about 0.5 mg l −1 for ACIII and about 0.15 mg l −1 for cyt aa 3 from 12 l of culture. Analytical methods. The total protein concentration was determined using the BCA kit (Thermo Scientific, Pierce Protein Research Products). The UV-visible absorption spectra of the oxidized and reduced proteins were recorded on an Agilent Technologies spectrophotometer (model 8453). The pyridine haemochrome assay 27 was used to determine the concentration of haems present in the protein samples. The total haem c concentration was divided by seven to calculate the ACIII concentration and the total haem a concentration was divided by two to calculate the cyt aa 3 concentration. The purified protein was analysed by SDS-PAGE using 4-20% precast gels (Nusep Tech). Haem staining was carried out using 3,3′,5,5′-tetramethyl benzidene (TMBZ) 28 . The supercomplex was visualized by blue native PAGE (BN-PAGE) using a 4-16% gel (Novex, Life Technologies) with Bis-Tris buffer. The entire gel was stained with Coomassie blue, and then fixed with 30% methanol and 10% glacial acetic acid. The gel was destained with 8% glacial acetic acid to visualize the bands. Peptide mass spectrometry and analyses were carried out by P. Yau at the Roy J. Carver Biotechnology Center at the University of Illinois at Urbana-Champaign. Oxygen consumption assay. Oxygen consumption was measured using a Clark electrode (Strathkelvin) in a 1 ml chamber at 25 °C as previously described 29 . The reaction mix consisted of 100 μM ubiquinone-1 (Q 1 ; Sigma-Aldrich) and 5 mM dithiothreitol in air-saturated 0.1 M potassium phosphate buffer, pH 7.5 with 150 mM NaCl. The reaction was started by adding the purified protein into the chamber. The initial concentration of oxygen was calculated to be 237 μM. Quinol:cytochrome c oxidoreductase activity. The quinol:cytochrome c oxidoreductase activity of the ACIII was measured spectrophotometrically as described previously 30 . The reaction was carried out in a 2 ml anaerobic cuvette, at 25 °C in 50 mM potassium phosphate buffer, pH 7.5 in the presence of 50 μM horse heart cytochrome c (Sigma-Aldrich) and 200 μM KCN. Ubiquinol-1 (Q 1 H 2 ) or reduced vitamin K 2 (Sigma-Aldrich) were used as quinol substrates and, in each case, the quinone was reduced using sodium borohydride according to a previously described method 31 . The reaction was started by the addition of 100 μM of reduced quinone. EPR spectroscopy. The purified ACIII-cyt aa 3 supercomplex was extensively dialysed against 20 mM Tris-HCl buffer, pH 8, with 150 mM NaCl and 1 mM EDTA to eliminate adventitious transition metal ions. The sample was concentrated in an Amicon filter to 150 μl with a final ACIII concentration of around 60 μM. The air-oxidized sample was directly transferred to an X-band EPR tube and subsequently frozen in liquid nitrogen. The sample was oxidized completely by the addition of 2 mM potassium ferricyanide. Glycerol (5%) was present in all EPR samples. Continuous wave EPR measurements were carried out on an X-band Varian EPR-E122 spectrometer at the Electron Paramagnetic Resonance facility at the University of Illinois at Urbana-Champaign. Cryogenic conditions below 77 K were achieved with a Lakeshore 331 temperature controller using a regulated flow of helium gas. Metal analysis. Metal analysis was carried out using inductively coupled plasma mass spectrometry (ICP-MS) as previously described 32, 33 . Optical redox titration. Full spectrum UV-visible redox titrations were performed to determine the midpoint potentials ( E m ) of the redox-active cytochromes in the DDM-solubilized ACIII-cyt aa 3 36 .Titrations were performed with an anaerobic stirred cuvette and the solution potential was adjusted by injecting aliquots of 10 mM sodium dithionite or potassium ferricyanide as reductant and oxidant, respectively. Spectra were taken at approximately 10-20-mV increments over the titration range indicated. Spectroscopic changes of the α-bands of the haems upon reduction or oxidation were monitored at the peak maxima to determine the midpoint potentials of each class of haem centre. The datasets were analysed using Origin (Origin Laboratory Corporation) to determine spectral components and fit titration curves using the Nernst equation 36 . Electron microscopy sample preparation. Holey carbon film-coated electron microscopy grids were nanofabricated with regular arrays of 500-to 800-nm holes 37 and coated with an additional layer of gold. Cryo-EM specimens were prepared with a FEI Vitrobot grid preparation robot at 4 °C and 100% humidity by applying 3 μl of sample (3 mg ml −1 ) to glow-discharged grids, allowing the grids to equilibrate for 1 s, and blotting for 12 s before freezing in a liquid ethane:propane mixture (1:1 v/v) 38 . Grids were subsequently stored in liquid nitrogen before shipping to the New York Structural Biology Center for imaging with a FEI Titan Krios electron microscope equipped with a Gatan K2 Summit camera and automated with Leginon 39 . Electron microscopy data acquisition. Movies were acquired in electron counting mode with a pixel size of 1.1 Å, an exposure rate of 7.4 electrons per pixel per second, and a total exposure time of 10 s divided in 40 frames (418 movies) or 50 frames (1,599 movies). Frame alignment and exposure weighting were performed with Motioncor2 40 . After screening averages from the aligned movies, 475 movies were discarded because of excessive movement, low defocus, high defocus, or overfocus. Contrast transfer function parameters were estimated from the exposure-weighted averages of movie frames with CTFFIND4 41 . Image processing. Particle images (3,044) were manually selected and subjected to 2D classification with Relion 1.4 42 . The resulting 2D classes were used as templates for automatic selection of 899,405 particle images 43 . The number of particle images was reduced to 693,416 by further 2D classification. Subsequent image processing was carried out in cryoSPARC 44 . An initial map of ACIII-cyt aa 3 was obtained Letter reSeArCH by ab initio 3D classification, refined to 4.1 Å resolution, and used as a reference for the multi-refine procedure in cryoSPARC producing initial maps of the ACIII and the ACIII-cyt aa 3 . Particle images (164,239) were used to refine the ACIII-cyt aa 3 map to 3.4 Å resolution, but this map showed the cyt aa 3 portion of the complex with lower density than the ACIII part. Maps with uniform density for ACIII-cyt aa 3 and ACIII, both at 3.6 Å resolution, were calculated from 81,530 and 51,547 particle images, respectively. Model building. The 3.4 Å resolution density map was used for the de novo model building of ACIII. The density map was first segmented with UCSF Chimera 45 to facilitate the identification of subunits. The connectivity of each segmented map was further examined and the result was compared with topology predictions from topocons 46 and secondary structure prediction from Jpred 47 to validate the subunit assignment and identify the directionality of peptide chain. With this information, model building was carried out manually in Coot 48 . Individual chains were first traced in Cα baton mode. Readily interpretable features from the density map, including regions rich in bulky residues, triacylated cysteines, and axial ligands of haem c, were used to register the structure to the sequence. Stretches of ~20 amino acids were built progressively around these registration points and assembled as a single chain in Coot. All six subunits of ACIII were combined and refined with phenix.real_space_refine 49 . For cofactors, the starting models were taken from the CCP4 ligand library directly. Cofactors were docked to the density map with Coot and merged with the apo protein structure. The complete structure was then refined with phenix.real_space_refine with geometric constraints for the protein-cofactor coordination. The final model was further examined in Coot to remove amino acid side chains with ambiguous orientations and further validated with MolProbity 50 and EMringer 51 . All identified lipids with two acyl tails were modelled as phosphatidylethanolamine with palmitoyl tail. The conformation of phosphatidylethanolamine was refined with interactive molecular dynamics flexible fitting (iMDFF) in the presence of the protein structure using VMD 52 . Lipid tails were then truncated according to the density map.
The 3.6 Å resolution ACIII-cyt aa 3 density map was used for the model building of cyt aa 3 . Part of the subunit III loop region was manually built in Coot. Homology models for individual subunits were generated with the RaptorX server 53 and docked into the density map with UCSF Chimera. The model for the ACIII-cyt aa 3 supercomplex was assembled by fitting the ACIII structure to the ACIII-cyt aa 3 map and placing the cyt aa 3 structure from Rba. sphaeroides (PDB 1M56) into the map based on the position of cyt aa 3 subunit III. Bioinformatic analysis. Homologous protein sequences were retrieved using the NCBI blastp server 54 . The blastp results were analysed in python 2.7 with pandas and biopython modules. Sequence hits were filtered on the basis of coverage and sequence identity. Representative sequences were selected on the basis of sequence identity to maintain the variations in sequence and aligned using the Clustal Omega server 55 . Figures for sequence alignment were prepared using the ESPript 3.0 server 56 . Simulation system preparation. The initial ACIII structure for the MD simulation was obtained from the refined structure determined by cryo-EM. Eleven 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine (POPE) lipids resolved by cryo-EM were added to the ACIII system, which was subsequently embedded in a POPE membrane bilayer, solvated with the TIP3P water model 57 , and ionized with 150 mM NaCl. ReMDFF simulation. Resolution-exchange molecular dynamics flexible fitting (ReMDFF) 58 was used for structure refinement, with the CHARMM36m force field for proteins 59 and the CHARMM36 force field for lipids 60 . Force-field parameters for haems and iron-sulfur clusters came from previous studies [61] [62] [63] . The fitting was performed in vacuum in the presence of a grid potential derived from the experimental density map (coupling factor 0.3). Secondary structure restraints, cis-peptide bond restraints, and chirality restraints were applied to the protein. Haems and iron-sulfur clusters were harmonically restrained (k = 50 kcal mol −1 Å −2 ). A Langevin thermostat 64 was used for maintaining the average temperature at 80 K. The MD integration time step was 1 fs. A cut-off radius for nonbonded interactions was set to 10 Å with a switching function taking effect at 9 Å. A total of six replicas were used together with six grid potentials of decreasing resolution. Each was first energy-minimized for 2,000 steps and then equilibrated for 1 ps. Finally, 2,000 replica exchanges were attempted with 1 ps between attempts. Molecular dynamics simulation. The ACIII systems were simulated with NAMD 2.12 using the same force-field parameters as in ReMDFF. The system was energyminimized for 3,000 steps using the conjugated gradient algorithm 65 with linear searching 66 , and equilibrated for 0.5 ns to relax lipid tail group atoms while keeping the lipid phosphorus atoms and protein (including haems and iron-sulfur clusters) heavy atoms harmonically restrained (k = 1 kcal mol −1 Å −2 ). This procedure was followed by a 10-ns simulation to allow lipids to relax around the proteins while keeping the protein backbone and heavy atoms from iron-sulfur clusters and haems harmonically restrained (k = 1 kcal mol −1 Å −2 ). Restraints were gradually released over the next 5 ns and the simulation continued without any biasing potential for a total of 250 ns. The angles in the iron-sulfur clusters were harmonically restrained to their initial values (k = 300 kcal mol −1 deg −1 ) throughout the simulation. Reporting summary. Further information on experimental design is available in the Nature Research Reporting Summary linked to this paper. Data availability. All relevant data are included in the manuscript or Supplementary Information and/or are available from the corresponding authors upon reasonable request. Three cryo-EM maps mentioned in this work have been deposited in the Electron Microscopy Data Bank (EMDB) under accession codes EMD-7286 (combined), EMD-7447 (ACIII-cyt aa 3 ), EMD-7448 (ACIII). The coordinates of the atomic model of the alternative complex III built from EMD-7286 have been deposited in the Protein Data Bank (PDB) under accession code 6BTM.
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Extended Data Fig. 1 | Expression and spectroscopic characterization of the ACIII-cyt aa 3 supercomplex. a, A schematic of the respiratory chain of F. johnsoniae. b, UV-visible spectrum and SDS-PAGE of the membranes from F. johnsoniae. Left, the difference spectrum of the membranes of F. johnsoniae, obtained from the spectrum of the airoxidized membranes and the spectrum after reduction with dithionite. The wavelengths associated with the haem peaks are 605 nm, 560 nm, 552 nm and a broad peak at 630 nm for haems a, b, c and d, respectively. Right, the SDS-PAGE with the membranes followed by staining the gel for haems shows bands corresponding to the cytochrome subunits ActA (48 kDa) and ActE (20 kDa) of ACIII but no bands corresponding to the cytochrome subunit (around 35 kDa) from the cbb 3 oxidase. c, The gene arrangement for the ACIII and the cytochrome oxidase aa 3 genes in the F. johnsoniae genome. The genes for the subunits I and II from cyt aa 3 oxidase are found immediately downstream of those for the act genes of the ACIII. Two different versions of subunit III are denoted as vI and vII. d, UV-visible spectra of the reduced and oxidized forms of the supercomplex in detergent and SMA nanodiscs. The dithionite reduced form of the samples is represented in red and shows the peaks for haem c at 524 nm and 552 nm and those for haem a at 443 nm and 605 nm. e, Pyridine haemochrome assay of the ACIII-cyt aa 3 supercomplex in SMA nanodiscs. Plotted is the reduced-minus-oxidized difference spectrum of the pyridine haemochromes of the sample. Peaks at 520 nm and 550 nm are associated with haem c and the peak at 590 nm is associated with haem a. Quantification from the spectrum shows a ratio of 10.6:1 between haem c and haem a, which translates into a 3:2 ratio between ACIII and cyt aa 3 assuming 7 haem c per ACIII and 2 haem a per cyt aa 3 . Data in b are representative of two independent experiments with similar results, and data in d and e are representative of six independent experiments with similar results.
Extended Data Fig. 7 | Fitting of the ACIII structure to cryo-EM density. a, Fitting of cofactors into the cryo-EM density. The blue mesh is drawn with a higher density threshold to reveal metal centres. The numberings of nearby amino acid residues, which are shown along with these cofactors, are listed below each cofactor. b, Fitting of different secondary structure elements to cryo-EM density. c, Eleven identified lipids are modelled as phosphatidylethanolamine molecules. d, The triacylated cysteine at the N terminus of ActE shown along with 15 downstream amino acids. Notably, residue Tyr28 is in contact with the covalent lipid of ActE. Attachment of ActE to the membrane may also be assisted by aromatic residues Tyr30 and Phe31, which appear to be inserted into the lipid bilayer. Throughout the molecular dynamics simulation trajectory, these residues remain buried in the lipid bilayer.
Extended Data Fig. 9 | Structural basis for supercomplex formation between the ACIII and the cyt aa 3 . a, Two contact areas between the ACIII and the cyt aa 3 : the transmembrane portion of subunit III (red) and the loop from subunit III (orange). A homology model of subunit III fits the transmembrane density. The loop is modelled to the cryo-EM density. The sequence of the peptide is also shown. Trp188 and Phe189 are used to register the density to the sequence. b, Model of the ACIII-cyt aa 3 supercomplex. The cyt aa 3 structure from Rba. sphaeroides was positioned based on the transmembrane portion of subunit III. α-helices 1 and 2 of subunit III are omitted to avoid steric clashes with the ACIII structure. c, Sequence alignment of subunit III with a long loop (highlighted with the orange bar) between α-helix 5 and α-helix 6 (numbered according to subunit III from Rba. sphaeroides). Trp188 (black arrow) is conserved. d, Sequence alignment of ActB from organisms with a long loop in subunit III of their cyt aa 3 oxidase. Arg868 (red arrow) is largely conserved with occasional substitution to lysine. Corresponding author(s): Robert B Gennis
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Experimental design 1. Sample size
Describe how sample size was determined.
No statistical methods were used to predetermine sample size. The sample size was chosen following the guidelines from the instrument manufacturer.
Data exclusions
Describe any data exclusions. A fraction of the acquired cryo-EM movies were discarded because of excessive movement, low defocus, high defocus, or over-focus.
Replication
Describe whether the experimental findings were reliably reproduced.
cyro-EM Data collection and structure calculation were not repeated.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
Samples were not allocated into experimental groups because the goal of this study was not to evaluate the impact of a particular factor, but to simply determine the structure of a protein.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
Not applicable. There was no existing protein structure to refer to and the data analysis was ab initio.
Note: all studies involving animals and/or human research participants must disclose whether blinding and randomization were used.
Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
